These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11302815)

  • 1. Improved efficacy of ciprofloxacin administered in polyethylene glycol-coated liposomes for treatment of Klebsiella pneumoniae pneumonia in rats.
    Bakker-Woudenberg IA; ten Kate MT; Guo L; Working P; Mouton JW
    Antimicrob Agents Chemother; 2001 May; 45(5):1487-92. PubMed ID: 11302815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciprofloxacin in polyethylene glycol-coated liposomes: efficacy in rat models of acute or chronic Pseudomonas aeruginosa infection.
    Bakker-Woudenberg IA; ten Kate MT; Guo L; Working P; Mouton JW
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2575-81. PubMed ID: 12121935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic efficacy of liposome-encapsulated gentamicin in rat Klebsiella pneumoniae pneumonia in relation to impaired host defense and low bacterial susceptibility to gentamicin.
    Schiffelers RM; Storm G; ten Kate MT; Bakker-Woudenberg IA
    Antimicrob Agents Chemother; 2001 Feb; 45(2):464-70. PubMed ID: 11158742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-circulating sterically stabilized liposomes in the treatment of infections.
    Bakker-Woudenberg IA; Schiffelers RM; Storm G; Becker MJ; Guo L
    Methods Enzymol; 2005; 391():228-60. PubMed ID: 15721385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of ciprofloxacin and levofloxacin in experimental pneumonia caused by Klebsiella pneumoniae deficient in porins, expressing active efflux and producing QnrA1.
    Rodríguez-Martínez JM; Pichardo C; García I; Pachón-Ibañez ME; Docobo-Pérez F; Pascual A; Pachón J; Martínez-Martínez L
    Clin Microbiol Infect; 2008 Jul; 14(7):691-7. PubMed ID: 18558942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
    Odenholt I; Cars O
    J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of gentamicin or ceftazidime entrapped in liposomes with prolonged blood circulation and enhanced localization in Klebsiella pneumoniae-infected lung tissue.
    Bakker-Woudenberg IA; ten Kate MT; Stearne-Cullen LE; Woodle MC
    J Infect Dis; 1995 Apr; 171(4):938-47. PubMed ID: 7706822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics and use of Monte Carlo simulation to evaluate currently recommended dosing regimens of ciprofloxacin in adult patients with cystic fibrosis.
    Montgomery MJ; Beringer PM; Aminimanizani A; Louie SG; Shapiro BJ; Jelliffe R; Gill MA
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3468-73. PubMed ID: 11709326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomes with prolonged blood circulation and selective localization in Klebsiella pneumoniae-infected lung tissue.
    Bakker-Woudenberg IA; Lokerse AF; ten Kate MT; Mouton JW; Woodle MC; Storm G
    J Infect Dis; 1993 Jul; 168(1):164-71. PubMed ID: 8515105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of sterically stabilized liposomes in experimental rat Klebsiella pneumoniae pneumonia: dependence on circulation kinetics and presence of poly(ethylene)glycol coating.
    Schiffelers RM; Bakker-Woudenberg IA; Storm G
    Biochim Biophys Acta; 2000 Sep; 1468(1-2):253-61. PubMed ID: 11018669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomal topotecan formulation with a low polyethylene glycol grafting density: pharmacokinetics and antitumour activity.
    Li C; Wang C; Yang H; Zhao X; Wei N; Cui J
    J Pharm Pharmacol; 2012 Mar; 64(3):372-82. PubMed ID: 22309269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy of liposomal gentamicin in clinically relevant rat models.
    Schiffelers RM; Storm G; Bakker-Woudenberg IA
    Int J Pharm; 2001 Feb; 214(1-2):103-5. PubMed ID: 11282246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rufloxacin once daily versus ciprofloxacin twice daily in the treatment of patients with acute uncomplicated pyelonephritis.
    Bach D; van den Berg-Segers A; Hübner A; van Breukelen G; Cesana M; Plétan Y
    J Urol; 1995 Jul; 154(1):19-24. PubMed ID: 7776420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo synergistic interaction of liposome-coencapsulated gentamicin and ceftazidime.
    Schiffelers RM; Storm G; ten Kate MT; Stearne-Cullen LE; den Hollander JG; Verbrugh HA; Bakker-Woudenberg IA
    J Pharmacol Exp Ther; 2001 Jul; 298(1):369-75. PubMed ID: 11408564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the duration of infection on the activity of ceftazidime, gentamicin and ciprofloxacin in Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats.
    Roosendaal R; Bakker-Woudenberg IA; van den Berghe-van Raffe M; Vink-van den Berg JC; Michel MF
    Eur J Clin Microbiol Infect Dis; 1991 Dec; 10(12):1019-25. PubMed ID: 1839380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of dose frequency on the therapeutic efficacies of ciprofloxacin and ceftazidime in experimental Klebsiella pneumoniae pneumonia and septicemia in relation to their bactericidal activities in vitro.
    Roosendaal R; Bakker-Woudenberg IA; van den Berghe-van Raffe M; Vink-van den Berg JC; Michel MF
    Pharm Weekbl Sci; 1987 Dec; 9 Suppl():S33-40. PubMed ID: 3325928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient drug delivery to lung epithelial lining fluid by aerosolization of ciprofloxacin incorporated into PEGylated liposomes for treatment of respiratory infections.
    Chono S; Suzuki H; Togami K; Morimoto K
    Drug Dev Ind Pharm; 2011 Apr; 37(4):367-72. PubMed ID: 20815792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of trovafloxacin in the treatment of Klebsiella pneumoniae lung infection in tumour-bearing mice.
    Thadepalli H; Reddy U; Chuah SK; Hanna N; Rana G; Gollapudi S
    J Antimicrob Chemother; 2000 Jan; 45(1):69-75. PubMed ID: 10629015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of liposome-encapsulated ciprofloxacin compared with ciprofloxacin and ceftriaxone in a rat model of pneumococcal pneumonia.
    Ellbogen MH; Olsen KM; Gentry-Nielsen MJ; Preheim LC
    J Antimicrob Chemother; 2003 Jan; 51(1):83-91. PubMed ID: 12493791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic/pharmacodynamic (PK/PD) evaluation of a once-daily treatment using ciprofloxacin in an extended-release dosage form.
    Schuck EL; Dalhoff A; Stass H; Derendorf H
    Infection; 2005 Dec; 33 Suppl 2():22-8. PubMed ID: 16518708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.